The pharmaceutical industry has expanded rapidly over the past few years, and regulatory scrutiny has grown right alongside it. Every stage of getting a drug from a lab to a patient, manufacturing, testing, distribution, packaging, is subject to inspection, and the margin for error is essentially zero.
Out of the hundreds of drugs pharma companies pursue each year, only a small fraction ever receive FDA approval, which shows just how exacting the standard already is before compliance even enters the picture.
